GlaxoSmithKline said this morning that a vaccine that could help prevent an outbreak of the H5N1 'bird flu' virus had been approved by the European Commission. The vaccine, Prepandrix, is the first
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
GlaxoSmithKline (GSK plc) announced that the European Commission has granted a marketing authorisation for its H5N1 adjuvanted pre-pandemic vaccine, Prepandrix™, in all 27 EU member states. GSK is th
read more » Discuss Add this link to...Bury Add to:
| Bookmarks